MAPT and Alzheimer disease: AD, AD + YP, and AD + EYP groups showed significantly decreased p-GSK3β/GSK3β ratios (p < 0.001) and significantly increased p-tau (Ser262, Thr205)/tau ratios (p < 0.001) compared with the CON group.